February 13, 2026 02:45 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
BJP MP files notice to cancel Rahul Gandhi's Lok Sabha membership, seeks life-long ban | Arrested in the morning, out by evening: Tycoon’s son walks free in Lamborghini crash case | ‘Why should you denigrate a section of society?’: Supreme Court pulls up ‘Ghooskhor Pandat’ makers | Bangladesh poll manifestos mirror India’s welfare schemes as BNP, Jamaat bet big on women, freebies | Drama ends: Pakistan makes U-turn on India boycott, to play T20 World Cup clash as per schedule | ‘Won’t allow any impediment in SIR’: Supreme Court pulls up Mamata govt over delay in sharing officers’ details | India-US trade deal: ‘Negotiations always two-way’, says Amul MD amid farmers’ concerns | Khamenei breaks 37-year-old ritual for first time amid escalating Iran-US tensions | India must push for energy independence amid global uncertainty: Vedanta chairman Anil Agarwal | Kanpur horror: Lamborghini driven by businessman’s son rams vehicles, injures six
Omicron
Unsplash

Omicron strain found in 63 countries, might surpass Delta in spreading speed: WHO

| @indiablooms | Dec 13, 2021, at 04:00 am

Geneva/UNI/Sputnik: The new Omicron coronavirus strain was found in 63 countries and, according to preliminary data, it will exceed Delta's spreading speed in the world, the World Health Organization (WHO) said.

"As of 9 December 2021, cases of human infections with this variant have been identified in 63 countries across all six WHO regions," the overview by the WHO read.

It is not clear yet, why the new strain is spreading so fast, the organization added.

"However, given the current available data, it is likely that Omicron will outpace the Delta variant where community transmission occurs," the document said.

The Omicron variant might reduce the effectiveness of COVID-19 vaccines based on preliminary data, but this strain is less dangerous than Delta, the organization assumed.

"There are limited available data, and no peer-reviewed evidence, on vaccine efficacy or effectiveness to date for Omicron. Preliminary evidence, and the considerably altered antigenic profile of the Omicron spike protein, suggests a reduction in vaccine efficacy against infection and transmission associated with Omicron," the statement said.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.